Detalhe da pesquisa
1.
Association between P1NP value and increases in bone mineral density in patients with postmenopausal osteoporosis treated with romosozumab.
Mod Rheumatol
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300506
2.
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration.
Mod Rheumatol
; 33(1): 96-103, 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35234889
3.
Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study.
Mod Rheumatol
; 33(5): 891-898, 2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975317
4.
Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Mod Rheumatol
; 33(2): 292-301, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289372
5.
The Association of Bohler's Angle With Postoperative Pain and Gender for Displaced Intra-Articular Calcaneal Fracture, Multicenter Retrospective Study-TRON Study.
J Foot Ankle Surg
; 61(4): 766-770, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933790
6.
Plate fixation through the lateral extensile approach versus cannulated screw fixation through the sinus tarsi approach for calcaneal fracture: a multicenter, propensity score-matched TRON study.
Eur J Orthop Surg Traumatol
; 32(7): 1333-1340, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499226
7.
Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors.
Mod Rheumatol
; 31(1): 80-87, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32148143
8.
Higher doses of methotrexate associated with discontinuation of oral glucocorticoids after initiation of biological DMARDs: A retrospective observational study based on data from a Japanese multicenter registry study.
Mod Rheumatol
; 31(4): 796-802, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33492191
9.
Improvement in matrix metalloproteinase-3 independently predicts low disease activity at 52 weeks in bio-switch rheumatoid arthritis patients treated with abatacept.
Clin Exp Rheumatol
; 38(5): 933-939, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083543
10.
Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study.
Mod Rheumatol
; 30(3): 434-441, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390271
11.
Clinical effectiveness and long-term retention of abatacept in elderly rheumatoid arthritis patients: Results from a multicenter registry system.
Mod Rheumatol
; 29(6): 910-918, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30220237
12.
Disuse Atrophy Accompanied by Intramuscular Ectopic Adipogenesis in Vastus Medialis Muscle of Advanced Osteoarthritis Patients.
Am J Pathol
; 187(12): 2674-2685, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28919112
13.
High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumab.
Mod Rheumatol
; 28(1): 119-125, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28463029
14.
Predictors of biologic discontinuation due to insufficient response in patients with rheumatoid arthritis who achieved clinical remission with biologic treatment: A multicenter observational cohort study.
Mod Rheumatol
; 28(2): 221-226, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28701065
15.
Disease activity early in treatment as a predictor of future low disease activity in RA patients treated with iguratimod.
Mod Rheumatol
; 26(2): 169-74, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26140467
16.
Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study.
Rheumatology (Oxford)
; 54(5): 854-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25339638
17.
Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.
Rheumatol Int
; 35(10): 1707-16, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25991396
18.
Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate.
Mod Rheumatol
; 25(2): 251-6, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25211402
19.
Progression of cervical instabilities in patients with rheumatoid arthritis 5.7 years after their first lower limb arthroplasty.
Mod Rheumatol
; 22(5): 743-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22245951
20.
Effect of total arthroplasty combined with anti-tumor necrosis factor agents in attenuating systemic disease activity in patients with rheumatoid arthritis.
Mod Rheumatol
; 22(3): 363-9, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21979824